Search

Patients with high-grade epithelial ovarian cancer with recurrence after neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) had similar outcomes following secondary cytoreduction surgery (SCS) compared to patients with recurrence after primary debulking surgery (PDS), according to a retrospective study by Memorial Sloan Kettering Cancer Center (MSK) Team Ovary.

… Tuesday, September 5, 2023 Patients with high-grade epithelial  ovarian cancer with recurrence after neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) had similar outcomes following secondary cytoreduction surgery (SCS) compared to patients with recurrence after primary debulking

A glimpse into the world of two Gerstner Sloan Kettering Graduate School students.

… Sunday, March 1, 2009 Summary A glimpse into the world of two Gerstner Sloan Kettering Graduate School students. On January 13, Armine Matevossian , a first-year student at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences , was already in the second week of her second laboratory rotation

Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.

… Friday, October 1, 2021 Every day, your dollars are accelerating today’s most daring discoveries straight into lifesaving care. Read more to learn about your impact. The Society’s 2021–2022 Campaign The Society of Memorial Sloan Kettering has supported cancer research, patient care, and education at

Dr. Marks was a towering figure who left a profound legacy.

… Friday, May 8, 2020 Summary Former Memorial Sloan Kettering President Paul Marks, who died April 28, 2020, was influential in shaping modern cancer research. He will be remembered as an inspiring researcher, dedicated mentor, and visionary leader. As a young physician in the 1950s, Paul Marks was fascinated

A team of doctors and researchers at MSK have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked. Learn how one 19-year-old patient sparked a detective story.

… Wednesday, September 11, 2024 A team of doctors and researchers at Memorial Sloan Kettering Cancer Center (MSK) have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked. Their findings, which include a detailed analysis of the clinical and

Un equipo de médicos e investigadores de MSK ha identificado un nuevo y raro tipo de cáncer pulmonar de células pequeñas que afecta principalmente a personas jóvenes que nunca han fumado. Descubra cómo un paciente de 19 años inspiró una historia de investigación.

… Wednesday, September 11, 2024 Un equipo de médicos e investigadores del Memorial Sloan Kettering Cancer Center (MSK) ha identificado un nuevo y raro tipo de cáncer pulmonar de células pequeñas que afecta principalmente a personas jóvenes que nunca han fumado. Sus hallazgos, que incluyen un análisis detallado

A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.

… Wednesday, September 25, 2013 Summary A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis. A new imaging approach being investigated by Memorial Sloan Kettering researchers

With notable cases of pancreatic cancer in the news this year, MSK held an Information Session for Patients and Caregivers with the goal of helping people understand the disease and sharing some of the encouraging breakthroughs in research and treatment.

… Monday, November 23, 2020 With notable cases of pancreatic cancer in the news this year, MSK held an Information Session for Patients and Caregivers with the goal of helping people understand the disease and sharing some of the encouraging breakthroughs in research and treatment. The session was moderated

Memorial Sloan Kettering Cancer Center (MSK) has welcomed Whitney Snider, MD, MBA, as the inaugural Managing Partner of MSK Ventures – a dedicated investment pool that will raise and direct funds to high-growth, early-stage startups created and/or nurtured by MSK faculty and staff.

… Tuesday, January 20, 2026 Memorial Sloan Kettering Cancer Center (MSK) has welcomed Whitney Snider, MD, MBA, as the inaugural Managing Partner of MSK Ventures – a dedicated investment pool that will raise and direct funds to high-growth, early-stage startups created and/or nurtured by MSK faculty and

A clinical trial led by MSK sarcoma expert Mrinal Gounder has shown promising results for treating desmoid tumors.

… Thursday, December 20, 2018 Summary Thanks to a clinical trial at MSK, college administrator Kirt Robinson was able to receive targeted therapy for an inoperable desmoid tumor. When Kirt Robinson, now age 43, started feeling pain in his neck about three years ago, he thought that he’d pulled a muscle